OVERHAUL CLINICAL TRIALS, SAYS NIH
Procedures for clinical trials must be revised to protect the public and restore public faith in medicine, says the director of the US National Institutes of Health, Elias Zerhouni. He has released an eight-point plan to improve trials and reduce the prospect of ignoring adverse results.
A key recommendation is to give equal weight to safety and efficacy. The NIH feels that a focus on efficacy was one of the problems that ultimately led to the 2004 withdrawal of Merck’s pain killer Vioxx. It has also called for researchers to treat prior observations with greater scepticism, pointing to flaws in studies of hormone replacement therapy, which appears to be associated with a higher risk of circulatory disease. Statistics can also mislead both practitioners and patients, says the NIH, particularly when drug efficacy is discussed in terms of relative risk without reference to the absolute risk.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicideāagain - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Are Dutch doctors too willing to euthanise people with autism and intellectual disability?
Will legalized euthanasia and assisted suicide lead to unnecessary deaths because of an able-ist bias against intellectual disability and autism?...
Euthanasia in Quebec: seamless service at a friendly funeral parlour
In Quebec, the number of cases of euthanasia has risen from 63 in 2015-2016 to 3663 in 2021-2022. Nowadays many...
Against commercial-assisted suicide
The journal Bioethics recently published an attack on commercial assisted suicide (CAS). The author, Yoann Della Croce, condemns it as...
Norway to export sperm
Danish sperm banks have grown into a successful export industry. Now Norway seems to be following the same path. The...
Denmark: parliament pressured to OK euthanasia
A proposal to legalise euthanasia in Denmark has broken the threshold of 50,000 signatures to put it before the Danish...
Australian judges need to review standards for gender dysphoria treatment
Most judges and lawyers in Australia know little about the white-hot debate amongst doctors over appropriate treatment for gender-dysphoric children....